A detailed history of Chris Davis (Davis Selected Advisers) transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Davis Selected Advisers holds 2,390,828 shares of DGX stock, worth $328 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
2,390,828
Previous 2,381,163 0.41%
Holding current value
$328 Million
Previous $317 Million 3.25%
% of portfolio
1.9%
Previous 1.78%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$125.91 - $144.34 $1.22 Million - $1.4 Million
9,665 Added 0.41%
2,390,828 $327 Million
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $35.3 Million - $40.6 Million
-285,401 Reduced 10.7%
2,381,163 $317 Million
Q4 2023

Feb 12, 2024

BUY
$120.62 - $141.12 $120 Million - $141 Million
998,866 Added 59.89%
2,666,564 $368 Million
Q3 2023

Nov 09, 2023

BUY
$121.86 - $144.92 $18.7 Million - $22.3 Million
153,810 Added 10.16%
1,667,698 $203 Million
Q2 2023

Aug 09, 2023

SELL
$130.56 - $146.84 $635,043 - $714,229
-4,864 Reduced 0.32%
1,513,888 $213 Million
Q1 2023

May 08, 2023

SELL
$131.53 - $155.76 $41.7 Million - $49.4 Million
-317,071 Reduced 17.27%
1,518,752 $215 Million
Q4 2022

Feb 10, 2023

SELL
$123.31 - $157.26 $4.36 Million - $5.56 Million
-35,337 Reduced 1.89%
1,835,823 $287 Million
Q3 2022

Nov 10, 2022

SELL
$121.77 - $141.1 $2.27 Million - $2.63 Million
-18,655 Reduced 0.99%
1,871,160 $230 Million
Q2 2022

Aug 11, 2022

SELL
$127.07 - $145.39 $7.27 Million - $8.32 Million
-57,243 Reduced 2.94%
1,889,815 $251 Million
Q1 2022

May 12, 2022

SELL
$129.09 - $164.35 $7.69 Million - $9.79 Million
-59,570 Reduced 2.97%
1,947,058 $266 Million
Q4 2021

Feb 11, 2022

SELL
$140.36 - $173.01 $103 Million - $127 Million
-736,328 Reduced 26.84%
2,006,628 $347 Million
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $9.66 Million - $11.5 Million
-72,658 Reduced 2.58%
2,742,956 $399 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $4.75 Million - $5.31 Million
37,508 Added 1.35%
2,815,614 $372 Million
Q1 2021

May 13, 2021

SELL
$114.63 - $133.34 $17.2 Million - $20 Million
-149,852 Reduced 5.12%
2,778,106 $357 Million
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $92.2 Million - $105 Million
-818,355 Reduced 21.84%
2,927,958 $349 Million
Q3 2020

Nov 12, 2020

SELL
$107.05 - $130.01 $13.7 Million - $16.7 Million
-128,261 Reduced 3.31%
3,746,313 $429 Million
Q2 2020

Aug 12, 2020

BUY
$73.34 - $122.61 $565,891 - $946,058
7,716 Added 0.2%
3,874,574 $442 Million
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $2.83 Million - $4.35 Million
-37,629 Reduced 0.96%
3,866,858 $311 Million
Q4 2019

Feb 13, 2020

SELL
$100.29 - $107.99 $7.42 Million - $7.99 Million
-73,965 Reduced 1.86%
3,904,487 $417 Million
Q3 2019

Nov 13, 2019

SELL
$97.85 - $107.42 $2.22 Million - $2.44 Million
-22,718 Reduced 0.57%
3,978,452 $426 Million
Q2 2019

Aug 13, 2019

BUY
$85.18 - $101.94 $30.8 Million - $36.9 Million
362,109 Added 9.95%
4,001,170 $407 Million
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $229 Million - $255 Million
2,840,669 Added 355.8%
3,639,061 $327 Million
Q4 2018

Feb 12, 2019

BUY
$79.75 - $108.38 $53.1 Million - $72.2 Million
665,853 Added 502.38%
798,392 $66.3 Million
Q3 2018

Nov 13, 2018

SELL
$105.42 - $114.99 $65,149 - $71,063
-618 Reduced 0.46%
132,539 $14.3 Million
Q2 2018

Aug 13, 2018

SELL
$97.35 - $113.14 $21,222 - $24,664
-218 Reduced 0.16%
133,157 $14.6 Million
Q1 2018

May 14, 2018

BUY
$96.42 - $107.88 $65,372 - $73,142
678 Added 0.51%
133,375 $13.4 Million
Q4 2017

Feb 13, 2018

BUY
$90.86 - $100.24 $3,816 - $4,210
42 Added 0.03%
132,697 $13.1 Million
Q3 2017

Nov 16, 2017

BUY
$91.96 - $108.35 $12.2 Million - $14.4 Million
132,655
132,655 $12.4 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track Chris Davis's Portfolio

Track Chris Davis Portfolio

Follow Chris Davis (Davis Selected Advisers) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Selected Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Davis Selected Advisers and Chris Davis with notifications on news.